Brown Advisory Inc Relay Therapeutics, Inc. Transaction History

Brown Advisory Inc

  • $72.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
BUY
$13.31 - $34.88 $16,531 - $43,320
1,242 Added 10.64%
12,914 $397,000
Q1 2022

Sep 13, 2022
SELL
$20.26 - $32.36 $25,162 - $40,191
-1,242 Reduced 9.62%
11,672 $349,000
Q4 2021

Jan 27, 2022
BUY
$26.0 - $37.03 $335,764 - $478,205
12,914 New
12,914 $397,000

Others Institutions Holding RLAY

# of Institutions
187
Shares Held
127M
Call Options Held
4.2K
Put Options Held
1.7K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $834M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email